Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 7/20 | 1.00 |
| ▸ | KDM2A | Q9Y2K7 | 7/20 | 1.00 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | KDM5C | P41229 | 4/20 | 1.00 |
| ▸ | KDM6B | O15054 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.60 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.55 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9839290 | 0.95 | PHF8 (0.90) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL61062 | 0.88 | KDM4E (0.78) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Succinylacetone SCHEMBL29120445 | 0.87 | PHF8 (0.75) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL15148024 | 0.84 | KDM4E (0.73) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL515966 | 0.84 | KDM4E (0.73) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Acetic Acid SCHEMBL30309106 | 0.83 | PHF8 (0.71) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL7016070 | 0.82 | KDM4E (0.70) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Succinic Acid SCHEMBL8382879 | 0.82 | PHF8 (0.70) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL6027524 | 0.82 | KDM4E (0.70) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL4098641 | 0.82 | PHF8 (0.68) | PHF8KDM2AEGLN1KDM4EKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250073321-A1 | Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and Disorders | UNIV NEW YORK (US) | 2025-03-06 | — | — | US | claimed |
| EP-4509174-A2 | COMPOSITIONS AND METHODS FOR PROMOTING SKIN HEALTH | The Regents of the University of California (US) | 2025-02-19 | — | — | EP | claimed |
| US-12162977-B2 | Blocked polyisocyanate crosslinking agent, its preparation method and a coating composition comprising the same | BASF COATINGS GMBH (DE) | 2024-12-10 | — | — | US | claimed |
| EP-3411011-B1 | COMPOSITIONS AND METHODS FOR PROMOTING SKIN HEALTH | UNIV CALIFORNIA (US) | 2024-09-18 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-114729100-B | Blocked polyisocyanate crosslinking agent, process for producing the same and coating composition comprising the same | 巴斯夫涂料有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-20220389153-A1 | A BLOCKED POLYISOCYANATE CROSSLINKING AGENT, ITS PREPARATION METHOD AND A COATING COMPOSITION COMPRISING THE SAME | BASF COATINGS GMBH (DE) | 2022-12-08 | — | — | US | claimed |
| EP-4058500-A1 | A BLOCKED POLYISOCYANATE CROSSLINKING AGENT, ITS PREPARATION METHOD AND A COATING COMPOSITION COMPRISING THE SAME | BASF Coatings GmbH (DE) | 2022-09-21 | — | — | EP | claimed |
| CN-114729100-A | Blocked polyisocyanate crosslinkers, process for their preparation and coating compositions comprising the crosslinkers | 巴斯夫涂料有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-7074770-B1 | Method of DNA vaccination | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-11 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-6573245-B1 | Conjugate including polysaccharide which binds to cell surface of Antigen Presenting Cell, protein or peptide antigen which elicits immunogenic response when covalently attached to polysaccharide, imine-forming compound | GALENICA PHARMACEUTICALS, INC. | 2003-06-03 | — | — | US | claimed |
| EP-1107785-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012121-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | PHF8 2309/4885KDM2A 1765/4885EGLN1 4717/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | PHF8 1523/4885KDM2A 1744/4885EGLN1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.